TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 90 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | -75.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 3,000 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 3,000 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | -11.1% | 3,000 | 0.0% | 0.00% | – |
| Q2 2018 | $9,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | -52.6% | 3,000 | 0.0% | 0.00% | – |
| Q4 2017 | $19,000 | -9.5% | 3,000 | 0.0% | 0.00% | – |
| Q3 2017 | $21,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2017 | $21,000 | -63.8% | 3,000 | -52.0% | 0.00% | -100.0% |
| Q1 2017 | $58,000 | +132.0% | 6,250 | 0.0% | 0.00% | – |
| Q4 2016 | $25,000 | +127.3% | 6,250 | +108.3% | 0.00% | – |
| Q3 2016 | $11,000 | -15.4% | 3,000 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | -7.1% | 3,000 | -2.3% | 0.00% | – |
| Q1 2016 | $14,000 | -54.8% | 3,072 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $31,000 | +34.8% | 3,072 | 0.0% | 0.00% | – |
| Q3 2015 | $23,000 | +187.5% | 3,072 | +1686.0% | 0.00% | – |
| Q2 2015 | $8,000 | +33.3% | 172 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q4 2014 | $7,000 | +133.3% | 172 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | +50.0% | 172 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | +100.0% | 172 | +72.0% | 0.00% | – |
| Q1 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |